Mario Renda

Telethon Institute Of Genetics And Medicine — Italy

Medicine · Health Sciences

11h-index564citations23works2.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Cystic Fibrosis Research Advances(7), Retinal Development and Disorders(5), Advanced biosensing and bioanalysis techniques(4), Genomics and Chromatin Dynamics(4), CRISPR and Genetic Engineering(4)

Publications23 total

A DNA base-specific sequence interposed between CRX and NRL contributes to RHODOPSIN expression
Scientific Reports·2024Open Access
Identification of 6,9-dihydro-5H-pyrrolo[3,2-h]quinazolines as a new class of F508del-CFTR correctors for the treatment of cystic fibrosis
European Journal of Medicinal Chemistry·2024· 5 citedOpen Access
Assessing the Potential of <i>N</i>-Butyl-<scp>l</scp>-deoxynojirimycin (<scp>l</scp>-NBDNJ) in Models of Cystic Fibrosis as a Promising Antibacterial Agent
ACS Pharmacology & Translational Science·2024· 3 citedOpen Access
Identification of Pyrrolo[3,2-H]Quinazolines as a New Class of F508del-Cftr Correctors for the Treatment of Cystic Fibrosis
SSRN Electronic Journal·2024Open Access
A DNA base-specific sequence interposed between CRX and NRL contributes to RHODOPSIN expression.
2023Open Access
Novel tricyclic pyrrolo-quinolines as pharmacological correctors of the mutant CFTR chloride channel
Scientific Reports·2023· 9 citedOpen Access
Comprehensive Analysis of Combinatorial Pharmacological Treatments to Correct Nonsense Mutations in the CFTR Gene
International Journal of Molecular Sciences·2021· 41 citedOpen Access
Partial Rescue of F508del-CFTR Stability and Trafficking Defects by Double Corrector Treatment
International Journal of Molecular Sciences·2021· 68 citedOpen Access
Evaluation of Fused Pyrrolothiazole Systems as Correctors of Mutant CFTR Protein
Molecules·2021· 26 citedOpen Access
Pharmacoproteomics pinpoints HSP70 interaction for correction of the most frequent Wilson disease-causing mutant of ATP7B
Proceedings of the National Academy of Sciences·2020· 15 citedOpen Access
The Autophagy Inhibitor Spautin-1 Antagonizes Rescue of Mutant CFTR Through an Autophagy-Independent and USP13-Mediated Mechanism
Frontiers in Pharmacology·2018· 27 citedOpen Access
Targeting and silencing of rhodopsin by ectopic expression of the transcription factor KLF15
JCI Insight·2017· 22 citedOpen Access
The centrosomal OFD1 protein interacts with the translation machinery and regulates the synthesis of specific targets
Scientific Reports·2017· 48 citedOpen Access
Gene-targeted transcriptional silencing by DNA-binding
Investigative Ophthalmology & Visual Science·2016Open Access
736. Silencing Substituting the RHODODPSIN Gene to Treat Blinding Disorders
Molecular Therapy·2016Open Access
320. Transcriptional Silencing via Synthetic DNA Binding Protein Lacking Canonical Repressor Domains as a Potent Tool to Generate Therapeutics
Molecular Therapy·2016Open Access
Rhodopsin targeted transcriptional silencing by DNA-binding
eLife·2016· 46 citedOpen Access
Author response: Rhodopsin targeted transcriptional silencing by DNA-binding
2016Open Access
484. Preclinical Proof of Concept of Transcriptional Silencing and Replacement Strategy for Treatment of Retinitis Pigmentosa Due To RHODOPSIN Mutations
Molecular Therapy·2015Open Access
Identification of binding sites of Lactobacillus plantarum enolase involved in the interaction with human plasminogen
Microbiological Research·2012· 27 cited
page 1 of 2Next →

Frequent Co-authors

Enrico Maria Surace(10), Salvatore Botta(9), Elena Marrocco(9), Martina Sofia(9), Maria Laura Bacci(9), Luis J. V. Galietta(8), Nicola de Prisco(7), Fabiola Curion(7), Mariangela Lupo(7), Settimio Rossi(7), Francesca Simonelli(7), Carlo Gesualdo(6), Ilaria Musante(4), Tiziano Bandiera(4), Virginia Spanò(4), Marilia Barreca(4), Alessandra Montalbano(4), Paola Barraja(4), Paolo V. Pedone(3), Anna Borrelli(3)